NCT02609490View on ClinicalTrials.gov

Azilsartan in Chinese Patients With Mild and Moderate Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

August 31, 2018

Conditions
Hypertension
Interventions
DRUG

Azilsartan tablets

20mg/tablet

DRUG

Azilsartan placebo tablets

placebo tablet

DRUG

Olmesartan medoxomil tablets

20mg/tablet

DRUG

olmesartan medoxomil placebo tablets

placebo tablet

Trial Locations (1)

100000

Peking University First hospiatl, Beijing

Sponsors
All Listed Sponsors
lead

Lee's Pharmaceutical Limited

INDUSTRY